Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | March 01, 2023 08:06am

Gainers

  • Reata Pharmaceuticals (NASDAQ:RETA) shares rose 175.1% to $85.75 during Wednesday's pre-market session. The company's market cap stands at $3.1 billion.
  • OncoSec Medical (NASDAQ:ONCS) stock increased by 99.07% to $2.15. The company's market cap stands at $6.3 million.
  • Vivos Therapeutics (NASDAQ:VVOS) shares moved upwards by 31.09% to $0.8. The company's market cap stands at $20.0 million.
  • Lucira Health (NASDAQ:LHDX) shares moved upwards by 23.65% to $1.15. The company's market cap stands at $46.6 million.
  • China Pharma Holding (AMEX:CPHI) shares rose 18.69% to $0.08. The company's market cap stands at $4.1 million.
  • Sarepta Therapeutics (NASDAQ:SRPT) shares moved upwards by 15.99% to $141.66. The company's market cap stands at $12.4 billion. As per the press release, Q4 earnings came out yesterday.

Losers

  • OKYO Pharma (NASDAQ:OKYO) stock fell 31.8% to $1.52 during Wednesday's pre-market session. The market value of their outstanding shares is at $33.1 million.
  • Novavax (NASDAQ:NVAX) shares declined by 27.87% to $6.68. The company's market cap stands at $567.8 million. The company's, Q4 earnings came out yesterday.
  • Ambrx Biopharma (NYSE:AMAM) stock declined by 19.13% to $5.2. The market value of their outstanding shares is at $200.8 million.
  • Adamis Pharmaceuticals (NASDAQ:ADMP) shares declined by 15.49% to $0.19. The company's market cap stands at $28.4 million.
  • FIGS (NYSE:FIGS) shares declined by 13.9% to $7.93. The company's market cap stands at $1.3 billion. The company's, Q4 earnings came out yesterday.
  • Catalyst Biosciences (NASDAQ:CBIO) stock decreased by 9.84% to $0.27. The company's market cap stands at $10.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADMP AMAM CBIO CPHI FIGS LHDX NVAX OKYO ONCS RETA SRPT VVOS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist